Synopsis
Synopsis
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 182349-12-8
2. Rupatadin Fumarate
3. Rupafin
4. Ur-12592 Fumarate
5. Rupatadine (fumarate)
6. Alergoliber
7. Rinialer
8. Xj6ot32m93
9. 182349-12-8 (fumarate)
10. Rupax
11. 8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-ylidene)-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine Fumarate
12. Rupatadine Fumarate (jan)
13. 1217234-48-4
14. Rupatadine Fumarate [jan]
15. (2e)-but-2-enedioic Acid; 13-chloro-2-{1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene}-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaene
16. 5h-benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinylidene]-, (2e)-2-butenedioate (1:1)
17. Mfcd00926499
18. Unii-xj6ot32m93
19. Rupatall
20. Tamalis
21. Wystamm
22. Ralif
23. Rinialer (tn)
24. 5h-benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(1-((5-methyl-3-pyridinyl)methyl)-4-piperidinylidene)-, (2e)-2-butenedioate (1:1)
25. Rupafin (tn)
26. Rupatadine Fumarate- Bio-x
27. 5h-benzo(5,6)cyclohepta(1,2-b)pyridine, 6,11-dihydro-8-chloro-11-(1-((5-methyl-3-pyridinyl)methyl)-4-piperidinylidene)-, (e)-2-butenedioate (1:1)
28. 8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidylidene]-5h-benzo[5,6]cyclohepta[1,2-b]pyridine Fumarate
29. Mls006010150
30. Schembl180121
31. Schembl180512
32. Rupatadine Fumarate [mi]
33. Hms3885k05
34. Bcp05230
35. Hy-13511a
36. Rupatadine Fumarate [who-dd]
37. S3052
38. Akos005145898
39. Ac-9016
40. Ccg-269922
41. Cs-3482
42. F76r825
43. Ks-1229
44. Br164385
45. Rupatadine Fumarate [ep Monograph]
46. Smr004701267
47. Sw219889-1
48. C73520
49. D08497
50. Q-201688
51. Q27293863
52. (e)-but-2-enedioic Acid;13-chloro-2-[1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
| Molecular Weight | 532.0 g/mol |
|---|---|
| Molecular Formula | C30H30ClN3O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 531.1924841 g/mol |
| Monoisotopic Mass | 531.1924841 g/mol |
| Topological Polar Surface Area | 104 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 728 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Treatment of allergic rhinitis, Treatment of chronic idiopathic urticaria
API SUPPLIERS
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
Certificate Number : CEP 2021-095 - Rev 00
Issue Date : 2024-07-10
Type : Chemical
Substance Number : 2888
Status : Valid
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Certificate Number : CEP 2023-016 - Rev 00
Issue Date : 2024-07-09
Type : Chemical
Substance Number : 2888
Status : Valid
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38451
Submission : 2023-05-31
Status : Active
Type : II
Certificate Number : CEP 2018-180 - Rev 03
Issue Date : 2025-04-01
Type : Chemical
Substance Number : 2888
Status : Valid
Date of Issue : 2022-06-15
Valid Till : 2025-07-14
Written Confirmation Number : WC-0183
Address of the Firm :
NDC Package Code : 66577-035
Start Marketing Date : 2018-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Hiple Co., Ltd.
Registration Date : 2020-09-04
Registration Number : Su30-4-ND
Manufacturer Name : Vasudha Pharma Chem Limited@ [Manufacturer of Desloratadine] Vasudha Pharma Chem Limited
Manufacturer Address : Unit-Ⅱ, Plot No. 79, Jawaharlal Nehru Pharma City, Thanam(V), Parawada(M), Anakapalli - 531019, Andhra Pradesh, India@ [Manufacturer of Desloratadine] Unit-I, Plot No. 37/A, 38, 39 A & B, Phase-I, IDA., Jeedimetla, Hyderabad – 500 055, Telangana, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36047
Submission : 2021-08-09
Status : Active
Type : II
Certificate Number : R1-CEP 2017-202 - Rev 00
Issue Date : 2023-08-09
Type : Chemical
Substance Number : 2888
Status : Valid
Registration Number : 228MF10183
Registrant's Address : Poli(´)gon Industrial Riera de Caldes Avinguda Cami(´) Reial 51-57 08184 Palau-Solita(´) i Pleamans Barcelona SPAIN
Initial Date of Registration : 2016-09-09
Latest Date of Registration :
Registrant Name : Ankuk Pharmaceutical Co., Ltd.
Registration Date : 2017-01-09
Registration Number : Su4532-1-ND
Manufacturer Name : Urquima SA
Manufacturer Address : Arnau de Vilanova 22-42 08105 Sant Fost de Campsentelles (Barcelona), Spain
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26210
Submission : 2012-09-27
Status : Inactive
Type : II
Registration Number : 306MF10071
Registrant's Address : Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, Gujarat, INDIA
Initial Date of Registration : 2024-05-29
Latest Date of Registration :
Date of Issue : 2022-09-01
Valid Till : 2025-07-02
Written Confirmation Number : WC-0074Amended
Address of the Firm :
Certificate Number : CEP 2024-018 - Rev 00
Issue Date : 2024-11-06
Type : Chemical
Substance Number : 2888
Status : Valid
Date of Issue : 2022-06-18
Valid Till : 2025-07-07
Written Confirmation Number : WC-0055n
Address of the Firm :
Registrant Name : Klasia Co., Ltd.
Registration Date : 2021-07-23
Registration Number : No. 173-28-ND(1)
Manufacturer Name : FDC Limited
Manufacturer Address : Plot No. 19 & 20/2, MIDC, Roha Industrial Area, Village Dhatav, Roha, Raigad 402 116, Maharashtra State, India
Certificate Number : R0-CEP 2018-213 - Rev 01
Issue Date : 2022-10-26
Type : Chemical
Substance Number : 2888
Status : Valid
Date of Issue : 2022-06-30
Valid Till : 2025-07-02
Written Confirmation Number : WC-0231n
Address of the Firm :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
About the Company : Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceutical products to Japan. In 2006, it acquired Pharmasynthèse. Today, Inabata...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-g...
About the Company : Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nationals Companies lik...
About the Company : Anlon Healthcare is a research-driven manufacturer of pharmaceutical bulk drugs and intermediates, based in Rajkot. Recognized globally for quality and regulatory compliance, our p...
About the Company : Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past six decades, we have been developing and manufacturing affordable ...
About the Company : Enaltec Labs was established in 2006 by a group of young & experienced professionals with the specific objective to develop & produce complex, small volume, technology driven produ...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : NOUCOR, headquartered near Barcelona, is a forward-thinking chemical-pharmaceutical company with a rich history spanning nearly two centuries. We operate three specialized manufact...
About the Company : Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
69
PharmaCompass offers a list of Rupatadine Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rupatadine Fumarate manufacturer or Rupatadine Fumarate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rupatadine Fumarate manufacturer or Rupatadine Fumarate supplier.
PharmaCompass also assists you with knowing the Rupatadine Fumarate API Price utilized in the formulation of products. Rupatadine Fumarate API Price is not always fixed or binding as the Rupatadine Fumarate Price is obtained through a variety of data sources. The Rupatadine Fumarate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rupatadine Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rupatadine Fumarate, including repackagers and relabelers. The FDA regulates Rupatadine Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rupatadine Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rupatadine Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rupatadine Fumarate supplier is an individual or a company that provides Rupatadine Fumarate active pharmaceutical ingredient (API) or Rupatadine Fumarate finished formulations upon request. The Rupatadine Fumarate suppliers may include Rupatadine Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Rupatadine Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rupatadine Fumarate DMF (Drug Master File) is a document detailing the whole manufacturing process of Rupatadine Fumarate active pharmaceutical ingredient (API) in detail. Different forms of Rupatadine Fumarate DMFs exist exist since differing nations have different regulations, such as Rupatadine Fumarate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rupatadine Fumarate DMF submitted to regulatory agencies in the US is known as a USDMF. Rupatadine Fumarate USDMF includes data on Rupatadine Fumarate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rupatadine Fumarate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rupatadine Fumarate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rupatadine Fumarate Drug Master File in Japan (Rupatadine Fumarate JDMF) empowers Rupatadine Fumarate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rupatadine Fumarate JDMF during the approval evaluation for pharmaceutical products. At the time of Rupatadine Fumarate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rupatadine Fumarate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rupatadine Fumarate Drug Master File in Korea (Rupatadine Fumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rupatadine Fumarate. The MFDS reviews the Rupatadine Fumarate KDMF as part of the drug registration process and uses the information provided in the Rupatadine Fumarate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rupatadine Fumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rupatadine Fumarate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rupatadine Fumarate suppliers with KDMF on PharmaCompass.
A Rupatadine Fumarate CEP of the European Pharmacopoeia monograph is often referred to as a Rupatadine Fumarate Certificate of Suitability (COS). The purpose of a Rupatadine Fumarate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rupatadine Fumarate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rupatadine Fumarate to their clients by showing that a Rupatadine Fumarate CEP has been issued for it. The manufacturer submits a Rupatadine Fumarate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rupatadine Fumarate CEP holder for the record. Additionally, the data presented in the Rupatadine Fumarate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rupatadine Fumarate DMF.
A Rupatadine Fumarate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rupatadine Fumarate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rupatadine Fumarate suppliers with CEP (COS) on PharmaCompass.
A Rupatadine Fumarate written confirmation (Rupatadine Fumarate WC) is an official document issued by a regulatory agency to a Rupatadine Fumarate manufacturer, verifying that the manufacturing facility of a Rupatadine Fumarate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rupatadine Fumarate APIs or Rupatadine Fumarate finished pharmaceutical products to another nation, regulatory agencies frequently require a Rupatadine Fumarate WC (written confirmation) as part of the regulatory process.
click here to find a list of Rupatadine Fumarate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rupatadine Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rupatadine Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rupatadine Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rupatadine Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rupatadine Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rupatadine Fumarate suppliers with NDC on PharmaCompass.
Rupatadine Fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rupatadine Fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rupatadine Fumarate GMP manufacturer or Rupatadine Fumarate GMP API supplier for your needs.
A Rupatadine Fumarate CoA (Certificate of Analysis) is a formal document that attests to Rupatadine Fumarate's compliance with Rupatadine Fumarate specifications and serves as a tool for batch-level quality control.
Rupatadine Fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Rupatadine Fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rupatadine Fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Rupatadine Fumarate EP), Rupatadine Fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rupatadine Fumarate USP).
